Acta Materia Medica (@AMM_journal) header
Acta Materia Medica (@AMM_journal) profile picture

An open platform for rapid publication of the latest pharmaceutical science research. Bluesky - https://teapawt.net/t.co/rkG5gUqXjz

Shannon, Ireland
Joined November 2021
Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)Photo by Acta Materia Medica (@AMM_journal)
Exploring advances in Cancer Therapeutics, Targets & Resistance from Acta Materia Medica Discover cutting-edge research: amm-journal.org/ #CancerResearch #CancerTherapeutics #DrugResistance #Oncology
7
1
681
Acta Materia Medica retweeted
This review examines how androgen receptor alterations contribute to CRPC and discusses PROTACs as tools for degrading proteins that sustain disease progression and therapeutic resistance. #CancerBiology #ProstateCancer @harvardmed #AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
1
1
1
34
Acta Materia Medica retweeted
A randomized trial found that Cs4 improved symptom severity, fatigue, insomnia, respiratory symptoms, and quality of life over 12 weeks in patients with long COVID. #ClinicalTrials #CordycepsSinensis @HKUniversity #AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
1
1
1
34
Acta Materia Medica retweeted
💊 Not every disease-associated molecular change is a promising drug target. In @DrugTargetRev , our Dr Shi-qi An explores how multiomics, single-cell and spatial technologies can strengthen drug target discovery. 🔗 drugtargetreview.com/home/ho…
1
1
51
Acta Materia Medica retweeted
Be Part of the Future of Pharmacology Join PHARMAUE 2026 – 18th International Conference & Exhibition on Pharmacology, Drug Discovery & Pharmacotherapy. Date: 8–9 December 2026 Venue: Kuala Lumpur, Malaysia & Virtual Register Now: pharmacy.ucgconferences.com/…
1
1
37
This review highlights microneedles as a user-friendly strategy for enhancing transdermal insulin transport while overcoming gastrointestinal and skin barriers. #Pharmaceutics #DrugDelivery #AMM #OpenAccess: doi.org/10.15212/AMM-2025-00…
1
27
Acta Materia Medica retweeted
Join us at these upcoming conferences: - Drug Discovery Chemistry Europe, November 10-12, Barcelona, Spain drugdiscoverychemistry.com/e… - The 43rd Medicinal Chemistry Symposium, November 11-13, Kyoto, Japan k-gakkai.jp/mcs2026/en/en_in… We will be happy to meet you, discuss the latest developments in Drug Discovery, and explore new opportunities for collaboration.
1
2
404
Acta Materia Medica retweeted
🇳🇱 Leiden University — PhD in AI-Driven Drug Discovery 🔥 URGENT | MSCA-Funded | Deadline: November 12, 2026 🏫 University: Leiden University 🔬 Laboratory: Leiden Academic Centre for Drug Research (LACDR) — Computational Drug Discovery Group 📍 Location: Leiden, Netherlands 🆕 Published: October 15, 2026 📖 Research Project: ANA-KIN DC10 — Deep Learning for Kinase Drug Discovery This PhD focuses on developing artificial intelligence models to discover new cancer therapeutics targeting protein kinases. Unlike conventional kinase inhibitors, which primarily target ATP-binding sites, the project investigates alternative regulatory interfaces to improve drug selectivity and overcome resistance. Research Activities: •Develop deep-learning models for kinase inhibitor discovery. •Integrate chemical, structural, and biophysical datasets. •Predict molecular binding and drug-resistance mechanisms. •Design computational approaches for peptide-based therapeutics. •Apply AI models to experimental drug-discovery workflows. •Develop open-source computational tools. The position includes research secondments at two Belgian partner organizations. 💰 Funding Details: ✅ Fully funded through the Horizon Europe MSCA Doctoral Network ANA-KIN. ✅ Four-year salaried PhD position. ✅ Gross monthly salary: €3,204–€4,051. ✅ Additional 8% holiday allowance. ✅ Additional 8.3% year-end allowance. ✅ University pension and employment benefits. ✅ International research secondments and specialist training. Contract Structure: Initial one-year appointment, extendable for the remaining three years after a positive evaluation. 🔍 Application Requirements: •Master’s degree in Computer Science, AI, Computational Chemistry, Bioinformatics, or a related field. •Experience with machine learning and deep learning, preferably PyTorch. •Knowledge of cheminformatics or computational chemistry. •Excellent Python programming skills. •Strong academic English. •Interest in pharmaceutical research. MSCA Eligibility: •Applicants must not already hold a doctoral degree. •Applicants must not have lived, worked, or studied in the Netherlands for more than 12 months during the preceding 36 months, subject to MSCA exceptions. Required Documents: •Motivation letter confirming MSCA eligibility. •Academic CV. •Academic grade list. •Contact details of two referees. 🕒 Application Deadline: November 12, 2026. ⏳ Time Remaining: 4 Days! ⭐ Why Apply? This is an excellent opportunity to combine artificial intelligence with pharmaceutical research. The project offers a competitive Dutch salary, international research experience, and collaboration with academic and industrial partners. 🔗 Official University Application: careers.universiteitleiden.n… #phd #PhD #phdopportunity #phdposition
1
2
72
Acta Materia Medica retweeted
POSTDOCTORAL FELLOWSHIPS IN MEDICINAL CHEMISTRY AT UNIVERSITY OF CAPE TOWN 👇👇👇👇👇👇👇👇 @PostdocPhd @PostdocO
3
1
1
74
Vicatia thibetica extract and chlorogenic acid improved skin structure, reduced oxidative stress, and enhanced epidermal barrier integrity in preclinical aging models. #Dermatology #SkinHealth #Aging #AMM #OpenAccess: doi.org/10.15212/AMM-2026-04…
19
👉
Apply for a job at University of Virginia: Faculty Position in Computational Chemistry / AI-Driven Drug Discovery (Open Rank) dlvr.​it/TWBjvF
26
👉
Artificial intelligence in drug discovery — what it is, where we stand and the path forward nature.com/articles/s41573-0… rdcu.be/AbCjmkuPETra This Perspective in the November issue provides recommendations to increase the translational relevance of AI uses in drug discovery
26
This study found that gut microbiota contributes to the pharmacokinetic interaction between berberine & astragaloside IV, with distinct interaction patterns observed in normal vs. T2DM rats. #Pharmacology #Diabetes #GutMicrobiota #AMM #OpenAccess: doi.org/10.15212/AMM-2024-00…
28